MPS Powered by Eureka

Current Psychopharmacology

ISSN: 2211-5560 (Print)
eISSN: 2211-5579 (Online)

Aims and Scope:Current Psychopharmacology publishes peer-reviewed expert reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology. Data must be published for the first time in Current Psychopharmacology.

Editor-in-Chief:


Kenneth Blum Department of Psychiatry
Western University Health Sciences
Pomona, CA
USA

Indexed in:


Cabell's Directory/Journalytics... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders

Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the current pharmacotherapeutic approaches to treating mental illnesses as well as drug delivery approaches that have improved existing therapies. Approaches to improve drug bioavailability, provide controlled... see more

Submission closes on: Dec 31, 2025
Neuromodulation for the treatment of psychiatric disorders

Neuromodulation techniques, including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), magnetic seizure therapy (MST), electroconvulsive therapy (ECT), theta burst stimulation (TBS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS), have been widely employed in the therapeutic management of prevalent psychiatric conditions such as major depressive disorder (MDD), bipolar disorder, and schizophrenia. The primary objective of this special edition of the Current Psychopharmacology is to provide an overview... see more